SCHEMBL22149115

SCHEMBL22149115

COc1cc(Nc2ccc3ncc(-c4ccc(N5CCNCC5)nc4)nc3c2)cc(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 4/20 0.61
KDR P35968 4/20 0.61
ZAP70 P43403 4/20 0.52
PRKD3 O94806 1/20 0.52
EGFR P00533 1/20 0.52
PRKCG P05129 1/20 0.52
PRKCB P05771 1/20 0.52
LCK P06239 1/20 0.52
PRKCA P17252 1/20 0.52
PRKCH P24723 1/20 0.52
PRKCI P41743 1/20 0.52
PRKCE Q02156 1/20 0.52
PRKCQ Q04759 1/20 0.52
PRKCZ Q05513 1/20 0.52
PRKCD Q05655 1/20 0.52
PRKD1 Q15139 1/20 0.52
KCNH2 Q12809 1/20 0.45
CACNA1C Q13936 1/20 0.45
ASIC3 Q9UHC3 1/20 0.45
MELK Q14680 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31655675 1.00 FGFR3 (0.61) FGFR3KDRZAP70PRKD3EGFR
SCHEMBL31655655 0.85 FGFR3 (0.54) FGFR3KDRZAP70PRKD3EGFR
SCHEMBL22149114 0.85 FGFR3 (0.54) FGFR3KDRZAP70PRKD3EGFR
SCHEMBL31655639 0.85 FGFR3 (0.54) FGFR3KDRZAP70PRKD3EGFR
SCHEMBL22149113 0.85 FGFR3 (0.54) FGFR3KDRZAP70PRKD3EGFR
SCHEMBL22149121 0.84 KDR (0.60) FGFR3KDRPRKCIFGFR1FGFR2
SCHEMBL6950873 0.80 ZAP70 (0.79) ZAP70PRKD3EGFRPRKCGPRKCB
SCHEMBL22149692 0.80 FGFR3 (0.50) FGFR3KDREGFRFGFR1FGFR2
SCHEMBL31655616 0.80 FGFR3 (0.50) FGFR3KDREGFRFGFR1FGFR2
SCHEMBL21554939 0.79 FGFR3 (0.65) FGFR3KDREGFRFGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020131674-A1 7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER ARRAY BIOPHARMA INC. (US) 2020-06-25 WO disclosed